PLATON

Welcome to the Brand page for “PLATON”, which is offered here for Products for medical use, pharmaceutical products for use in oncology, especially oligonucleotides, more particularly in the form of double-stranded dna acting as a decoy or false signal for proteins, especially enzymes, involved in tumor growth and/or tumor escape, more particularly dna binding proteins and especially tumor cell dna repair proteins for treating solid and/or liquid cancers;scientific, medical and pharmaceutical research for the research and identification of new pharmaceutical products limited to these oligonucleotides from a proprietary technology platform or chemo-library; pharmaceutical research and development limited to products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory research limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory analysis limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library;.

Its status is currently believed to be active. Its class is unavailable. “PLATON” is believed to be currently owned by “ONXEO”.